- Recent Funding
- Investors
- Vikram Dhingra
Vikram Dhingra portfolio
Vikram Dhingra has 1 portfolio company on record at Recent Funding.
About this page
It is an angel investor. Its most recent investment on record is Ultrahuman's $17.5M Series B+ round in August 2021, alongside Mohit Gupta, Steadview Capital, Roman Saini and 6 others. That company is in Health and bio.
What Vikram Dhingra invests in
- Health and bio · 1 · 100%
- Data and analytics · 1 · 100%
- Developer tools and cloud · 1 · 100%
How Vikram Dhingra invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $17.5M |
Vikram Dhingra portfolio companies
UUltrahuman$17.5MSeries B+ · Aug 2021
| Company | Round with Vikram Dhingra | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $17.5M | $155.82M | Jul 15, 2026 Series B+ |
Most frequent co-investors
SSteadview Capital1 shared round · last Aug 17, 2021
RRoman Saini1 shared round · last Aug 17, 2021
KKunal Shah1 shared round · last Aug 17, 2021
NNexus Venture Partners1 shared round · last Aug 17, 2021
SSujeet Kumar1 shared round · last Aug 17, 2021
IiSeed1 shared round · last Aug 17, 2021
- RRevant Bhate1 shared round · last Aug 17, 2021
- SScott Shleifer1 shared round · last Aug 17, 2021
MMohit Gupta1 shared round · last Aug 17, 2021
Similar investors
- MMike Chalfen3 companies · 1 deal in 12 mo
TTravis May3 companies · 1 deal in 12 mo
CChristopher Golda3 companies
EEsther Dyson3 companies
RRaymond Tonsing3 companies
ZZachery Coelius3 companies
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Vikram Dhingra. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Vikram Dhingra, which is a subset of its real portfolio. API: /api/v1/investors/vikram-dhingra (get a free API key). More: the most active VC firms and new venture capital funds.